Ola Oluwole Profile
Ola Oluwole

@OlaOluwole4

Followers
229
Following
61
Media
8
Statuses
66

Joined June 2018
Don't wanna be here? Send us removal request.
@OlaOluwole4
Ola Oluwole
2 years
With my good friends David and Veronika discussing my favorite topic, outpatient CAR at TCT!
0
0
12
@MistyEvansDNP
Misty Evans
2 years
Round 1: Haplo vs. Gene Therapy for Sickle Cell 🥊 #APPtrack #tandem2024@ASTCT
2
10
38
@OlaOluwole4
Ola Oluwole
2 years
Pls join my colleagues and I for this important symposium! Registration is free!
0
0
2
@KitePharma
Kite, a Gilead Company
2 years
#NEWS: Announcing detailed results from the overall survival analysis of the landmark Phase 3 study of #CARTcell therapy compared with historical standard of care as initial treatment for relapsed/refractory large B-cell lymphoma. #ASCO23
0
6
18
@Mohty_EBMT
Mohamad Mohty
3 years
Live from #EBMT23. Thank you all for joining. What a great transplant community ⁦@TheEBMT⁩ ⁦@TheEBMT_Nurses⁩ ⁦@TheIACH
1
27
142
@KitePharma
Kite, a Gilead Company
3 years
#NEWS: Today, we announced the primary overall survival (OS) analysis results, a key secondary endpoint, of our Phase 3 study of CAR T-cell therapy for initial treatment of relapsed/refractory large B-cell lymphoma.
1
30
46
@drkomanduri
Krishna Komanduri, MD, FASTCT
3 years
🎯🎉@ASTCT #Tandem23
@DrCCutler
Corey Cutler
3 years
Congratulations to @DrMiguelPerales who is taking over at the helm of @ASTCT. We're in for a good year.
0
4
22
@OlaOluwole4
Ola Oluwole
3 years
Our own Vivek ⁦⁦@vpatelmd⁩ presenting important data that CRS is not essential for response in CAR therapy at the TCT conf. Go Vivek!
0
5
33
@vpatelmd
Vivek Patel, MD
3 years
My awesome mentor @OlaOluwole4 chairing a session on moving CAR-T to the outpatient setting. Looking forward to improving patient quality of life #tandem23 @VUMC_Medicine @VUMC_Cancer
0
6
24
@DholariaMD
Bhagirath Dholaria, MD
3 years
@OlaOluwole4 It's our team's data, Ola. It takes a village for FULLY outpatient CAR/ALLO program @VUMC_Cancer @BipinSavani @DrAdetolaKassim @iNDUSBMT
0
2
8
@jordanberlin5
Dr. jordan berlin
3 years
our outstanding fellow @EdenBiltibo soon to be exceptional faculty @VUMCHemOnc @VUMC_Cancer @VUMC_Medicine
@JayaniReena
Reena Jayani-Kosarzycki
3 years
Wonderful poster by our @VUMCHemOnc fellows on desensitization strategy for patients with sickle cell disease undergoing BMT. @EdenBiltibo @VUMC_Cancer
0
2
18
@ResearchRNBritt
Brittney Baer
3 years
So proud of you @JayaniReena!!
@Ashley_Rosko1
Ashley Rosko
3 years
@JayaniReena taking the stage. Amazing how much work has been done in #geriheme #geribmt (!) in such a short time #Tandem23 @MunshiPashnaMD @ROlinMD @SarahAllison10 @DrRichardJLin
0
1
5
@TheIACH
IACH
3 years
📣Delighted to launch @TheIACH CAR-T News! Once a month, we will provide the hottest and latest developments and publications in #CARTcell #Cellular_therapy https://t.co/vFdQ5KIHkc @RShouval @Mohty_EBMT @nagler_EBMT
1
11
22
@ResearchRNBritt
Brittney Baer
3 years
@SarahAllison10
Sarah Wall, MD MPH
3 years
@Ashley_Rosko1 asking the important questions in SIG for Aging @ASTCT Spotlight Session with @JayaniReena @MunshiPashnaMD
0
1
2
@NausheenAhmedMD
Nausheen Ahmed MD
3 years
@BipinSavani , always need a mandatory selfie with my survivorship mentor !! @ASTCT_Journal #Tandem23
0
3
16